Methotrexate‐Induced Pulmonary Toxicity
Author(s) -
Baruch D. Jakubovic,
Andrea Donovan,
Peter M. Webster,
Neil H. Shear
Publication year - 2013
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2013/527912
Subject(s) - medicine , methotrexate , psoriasis , adverse effect , pulmonary toxicity , interstitial pneumonitis , pneumonitis , intensive care medicine , toxicity , hypersensitivity pneumonitis , pharmacovigilance , dermatology , pathogenesis , pharmacology , drug , lung , respiratory disease
Methotrexate is a widely used medication with an array of recognized side effects. The present report describes a case of methotrexate-induced pneumonitis in a patient with psoriasis, and demonstrates the hallmark clinical and investigational findings that support this infrequently encountered diagnosis. The ensuing discussion reviews the pathogenesis, management and prevention of this adverse drug reaction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom